CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-2-532-7151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change · Regulation FD disclosure
- PRE 14A Proxy Proxy Statement (Preliminary)
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- S-3 Offering Registration Statement
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
- D Other Notice of Sales of Unregistered Securities
- 4 Grant or award Director acquired 19,117 shares (grant or award)
- 4 Grant or award Director acquired 22,815 shares (grant or award)
- 4 Grant or award Director acquired 20,790 shares (grant or award)
- 4 Grant or award Director acquired 20,034 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 21 · 420 filings